Patent Assignment
Reel/Frame 049914/0399
Change of Name
Recorded: 2019-07-31
Pages: 8
Assignor
AERPIO THERAPEUTICS, INC.
Executed: 2017-03-15
Assignee
AERPIO THERAPEUTICS LLC
9987 CARVER ROAD, CINCINNATI, OHIO, 45242
Covered Properties
(5)
Antibodies That Target Human Protein Tyrosine Phosphatase-Beta (Hptp-Beta) and Methods of Use Thereof to Treat Ocular Conditions
Humanized Monoclonal Antibodies That Target Protein Tyrosine Phosphatase-Beta (Hptp-Beta / Ve-Ptp)
Methods of Treating Ocular Conditions by Administering Humanized Monoclonal Antibodies That Target Ve-Ptp (Hptp-Beta)
Humanized Monoclonal Antibody That Targets Ve-Ptp
Application:
62/364,381 →
Humanized Monoclonal Antibody That Targets Ve-Ptp
Application:
62/377,072 →
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 27, 2016
From: PETERS, KEVIN
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 039269/0016 →
Assignment of Assignor's Interest
Oct 25, 2016
From: PETERS, KEVIN
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 040121/0532 →
Assignment of Assignor's Interest
Jul 12, 2017
From: PETERS, KEVIN; FLYNN, MICHAEL ALLEN
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 042989/0445 →
Assignment of Assignor's Interest
Jul 12, 2017
From: PETERS, KEVIN; FLYNN, MICHAEL ALLEN
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 042989/0455 →
Assignment of Assignor's Interest
Jul 20, 2017
From: PETERS, KEVIN; FLYNN, MICHAEL ALLEN
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 043260/0580 →
Assignment of Assignor's Interest
Aug 29, 2017
From: PETERS, KEVIN; FLYNN, MICHAEL ALLEN
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 043438/0743 →
Assignment of Assignor's Interest
Nov 6, 2018
From: PETERS, KEVIN; FLYNN, MICHAEL ALLEN
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 047418/0426 →
Assignment of Assignor's Interest
Nov 6, 2018
From: PETERS, KEVIN; FLYNN, MICHAEL ALLEN
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 047418/0438 →
Assignment of Assignor's Interest
Apr 17, 2020
From: AERPIO THERAPEUTICS LLC
To: AERPIO PHARMACEUTICALS, INC.
Reel/Frame 052432/0789 →
Assignment of Assignor's Interest
Sep 9, 2021
From: AERPIO PHARMACEUTICALS, INC.
To: EYEPOINT PHARMACEUTICALS, INC.
Reel/Frame 057448/0033 →